Related Experiment Video
Updated: Sep 15, 2025

Control of Eating Behavior Using a Novel Feedback System
Published on: May 8, 2018
To eat or not to eat: A role for ghrelin and LEAP2 in eating disorders?
Virginie Tolle1, Chloe Tezenas du Montcel1,2, Julia Mattioni1
1Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Vulnerability of Psychiatric and Addictive Disorders, F-75014, Paris, France.
Abstract:
Ghrelin is an orexigenic hormone that orchestrates many diverse behaviours of relevance for feeding control. It appears to operate as a hunger hormone, organizing food intake into meals and ensuring that we seek out and consume a variety of foods. With this physiological biography, the ghrelin system, including the pathways through which it operates, has been interrogated for its role in the aetiology, pathology and treatment of eating disorders. While common obesity does not appear to be a hyperghrelinemic state, it would be difficult to completely rule out enhanced ghrelin signalling. At the other end of the body weight spectrum, it can be questioned whether patients suffering from anorexia nervosa develop ghrelin resistance and/or have high levels of LEAP2, an endogenous antagonist for GHSR, since they do not eat despite having high ghrelin levels. The purpose of this review is to outline gaps in knowledge in the ghrelin field, including in the context of eating disorders.
Related Concept Videos
Regulation of Food Intake
Binge Eating Disorders
Bulimia Nervosa
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Hormonal Regulation

